If you searched for the best online clinics for compounded semaglutide, you probably already have one in mind, or you are on a vial from one now and something has changed: the dose went up again, the results stopped, or a side effect is arriving that nobody has asked about. You want a short list of the good ones. This piece will not give you that list, and it owes you the reason.

GoodLife Health is a clinician-led membership that prescribes branded, FDA-approved GLP-1 medication only, and never compounded GLP-1. We are not on any list of the best online clinics for compounded semaglutide, by choice. What follows is what we looked at before making that choice, what the public record says as of October 2026, and what we think a good clinic looks like now that the compounding era has closed. We have a stake in the answer, so weigh it with that in mind.

Key Takeaways
  • Compounded semaglutide is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.
  • The legal basis for mass-producing it ended in 2025: the FDA declared the semaglutide shortage resolved on February 21, 2025, and the grace periods closed that April and May.
  • A ranking of compounded clinics compares the price of a vial; it cannot compare the thing that decides your result, which is whether anyone finds out why your body responds the way it does.
  • The branded medicine is now sold to self-pay patients at the manufacturer's published price, which removes the main reason compounding existed.
  • GoodLife Health tests first, prescribes branded medication to the pharmacy you choose at that pharmacy's price, and charges the same $299 a month whatever the medication or dose.

Why the list you are looking for keeps changing

Lists of online semaglutide clinics change every few months because the market underneath them changed. For several years semaglutide sat on the FDA's drug shortage list. While it did, federal law let two kinds of pharmacy make copies: state-licensed 503A pharmacies, which compound for an individual patient, and 503B outsourcing facilities, which can produce in larger volume. Hundreds of online clinics were built on that supply.

The shortage ended. The FDA declared it resolved on February 21, 2025, and gave compounders a short window to wind down: the grace period ended on April 22, 2025 for 503A pharmacies and on May 22, 2025 for 503B outsourcing facilities. The FDA's page on medications containing semaglutide sets out what changed. Narrow, individualized compounding for a documented clinical reason the approved product cannot meet still has legal footing. Shortage-era mass production does not.

So the clinic you found last year may have changed its product, its pharmacy or its claims since. A ranking written before May 2025 is ranking a market that no longer exists, and one written after it is often ranking how well a clinic has adjusted its wording. Neither tells you what you need to know.

What a ranking of compounded clinics cannot see

Most rankings compare the same handful of things: the monthly price, how fast the prescription arrives, whether the vial ships free, and how easy the app is to use. Those are real conveniences. They are also all things a seller controls, which is why they are easy to compare.

What they leave out is what decides your result. The FDA states plainly that compounded drugs are not FDA-approved and that the agency does not review them for safety, effectiveness or quality before they are marketed. Its page on unapproved GLP-1 drugs used for weight loss records adverse event reports involving compounded versions, including dosing errors and versions made with added ingredients. The FDA has also warned that some products sold as semaglutide were made from salt forms, semaglutide sodium and semaglutide acetate, which are not the active ingredient in the approved medicines.

None of that means every compounded vial is a bad vial. We do not claim it is. It means the information you would need to compare two compounded products, what exactly is in each one and how consistently, is information no ranking has. A list can rank the storefront. It cannot rank the contents.

And there is a second blind spot, which matters more to the reader who is already on medication. A ranking compares how quickly a clinic will prescribe. It does not ask what happens when the medication stops working at a high dose, when nausea or hair loss arrives, or when your thyroid, your insulin or a condition like polycystic ovary syndrome is the reason the scale stopped moving. In a prescribe-and-ship model, the usual answer to a plateau is the next dose. That is the moment a clinic shows what it is, and it is the moment no list measures.

Clinical note

If you are on compounded semaglutide now, do not stop it or change the dose on your own. Bring the label, the concentration and your dose history to a clinician, who decides whether and how to move you to a branded medicine.

What we decided, and why we left compounding out

When we built GoodLife Health, the choice about compounded GLP-1 was a choice about what we want to be responsible for. A clinician who prescribes puts a licence behind that prescription. We want that licence behind a medicine whose manufacturing, dose and contents are reviewed and labeled, and whose results come from the large trials that were run on that exact medicine.

So our clinicians prescribe branded, FDA-approved GLP-1 medication when it is clinically indicated: Wegovy, Zepbound, Mounjaro or Ozempic. We prescribe to the pharmacy you choose, and you pay that pharmacy its own price. We set nothing on the medication, see nothing on it and take nothing from it, which means no dose and no molecule makes us more money than another. We do not prescribe compounded GLP-1, ever, and we do not route prescriptions to compounding pharmacies.

That decision has a cost, and we would rather you hear it from us. Branded medication costs more than the cheapest compounded vial. Through NovoCare, Novo Nordisk's pharmacy program, Wegovy pens were listed in September 2026 at $199 a month for the first two fills, an introductory offer for new patients through December 2026, and $349 a month after that, and the Wegovy pill from $149 a month at lower doses, according to NovoCare's Wegovy page. Through LillyDirect, Zepbound vials were $299 to $449 a month depending on dose. Those are the manufacturers' own published prices, with their dates, and they are what you would pay a pharmacy, not us.

GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

What to look for in any clinic, including ours

If you are choosing where to be treated, these are the questions we would ask of anyone, and the answers we give to them.

Does it test before it treats? A GLP-1 works on a metabolism that has a cause. Fasting insulin, glucose and A1C, a lipid panel with ApoB, thyroid function and the markers that show how your liver and kidneys are handling treatment tell a clinician why you are where you are. Our membership includes four cardiometabolic lab panels a year, and every result is in your hands.

Does someone look at why it stopped working before raising the dose? Our clinicians work to a rule our clinical lead puts in one sentence: "I don't automatically increase a GLP-1 every month because the dosing schedule says that another dose exists." A plateau is a question to answer, not a cue to sell the next step.

Is the price of care separate from the price of the medicine? If a clinic's fee rises with your dose, its income rises with your dose. Ours does not: the membership is $299 a month whatever the medication and whatever the dose.

Will the same clinician still be there in six months? Our clinicians are licensed in all fifty states, and you reach the same care team by message and video.

Does it tell you who it is not for? A clinic that says yes to everyone is selling, not treating. We turn people away, and the section below says who.

Where this is going

The compounding era was built on two facts that are no longer true: the branded medicine was scarce, and the only way to buy it was through insurance at a list price most people could not see. In 2025 the FDA declared both shortages resolved. Now the manufacturers sell to self-pay patients directly, at published prices, through NovoCare and LillyDirect, and the Wegovy pill has arrived at a lower entry price than the pens.

What remains scarce is the part a vial never included: a diagnosis, the markers followed over time, and a clinician who decides with you whether the medicine should continue, change or stop. We think that is where weight and metabolic care is moving, from the prescription as the product to the diagnosis as the product, with the branded medicine bought at the pharmacy's own price. GoodLife Health is built for that version of care. If you read this far looking for the best compounded clinic, the honest answer is that the best clinic is the one that would ask why before it asks which dose.

What it costs, what it buys, and what it does not

The GoodLife Health membership is $299 a month, month to month. $598 is held on your card at sign-up, charged only once you are accepted, and covers the first two months. If a clinician cannot accept you into care, the $598 hold is released and you are never charged; once you are accepted, the first two months are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy.

It buys four cardiometabolic lab panels a year, a clinician who reads them with you and stays, messaging and video visits, and branded medication prescribed when indicated to the pharmacy you choose at that pharmacy's price. It returns the thing a prescribe-and-ship model never produced: the reason your body responds the way it does. It does not replace your health insurance, which you keep for hospital and catastrophic care, and it does not guarantee weight loss, insurance coverage of a medication, or acceptance into care. Not everyone is accepted. If you are already on compounded semaglutide, bring your history; the clinician starts with labs and decides with you, without a forced restart.

Who this is not for

If the lowest monthly price is your main test, GoodLife Health is not for you, and we would rather say so now. We do not compete with the $99-a-month compounded app, and we will not prescribe compounded GLP-1 to match it. The membership is also wrong for someone who wants a prescription without labs, for anyone under 18, pregnant or planning a pregnancy on a GLP-1, for someone who needs urgent or full-scope primary care, and for anyone outside the United States. And if $299 a month would be a strain, choose care you can sustain; we would rather you do that than start and leave.

The best clinic is the one that would ask why before it asks which dose.

Frequently Asked Questions

Why doesn't GoodLife Health appear on lists of the best online clinics for compounded semaglutide?

Because we do not prescribe compounded GLP-1. Our clinicians prescribe branded, FDA-approved medication only, to the pharmacy you choose at that pharmacy's price, and we take nothing on the medication.

Is compounded semaglutide still legal in 2026?

The broad legal basis for mass-producing it ended in 2025. The FDA declared the semaglutide shortage resolved on February 21, 2025, and the grace periods closed on April 22, 2025 for 503A pharmacies and on May 22, 2025 for 503B outsourcing facilities. Narrow, individualized compounding for a documented clinical reason still has legal footing.

I am on compounded semaglutide now. Can you move me to a branded medicine?

Bring your history to the intake. The clinician starts with labs, reviews your dose and how you have responded, and decides with you whether and how to move to a branded medicine. Do not stop or change your dose on your own.

What does the membership cost, and does it include the medication?

The membership is $299 a month, with $598 for the first two months held on your card at sign-up and charged only once you are accepted. Medication is separate: it is billed by your own pharmacy at its own price, and the membership fee is the same whatever the medication or dose.

Related Reading

References

  1. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  2. FDA: Medications Containing Semaglutide and Tirzepatide, Safety Information and Compounding. 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
  3. NovoCare Pharmacy: Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html